Pediatrix Medical (MD) Receivables - Other (2017 - 2024)

Pediatrix Medical (MD) has 8 years of Receivables - Other data on file, last reported at $28.5 million in Q4 2024.

• Receivables - Other for Q4 2024 came in at $28.5 million, down 14.16% year-over-year; the trailing twelve-month figure through Dec 2024 was $28.5 million (down 14.16% YoY), and the FY2024 annual result was $28.5 million, down 14.16% from the prior year.
• Receivables - Other eased to $28.5 million in Q4 2024 per MD's latest filing, from $33.2 million in the prior quarter.
• Over five years, Receivables - Other peaked at $61.4 million in Q4 2020 and troughed at $28.5 million in Q4 2024.
• A 5-year average of $47.2 million and a median of $54.7 million in 2022 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2020 and 2023: Receivables - Other surged 106.04% in 2020, then slumped 39.31% in 2023.
• A 5-year view of Receivables - Other shows it stood at $61.4 million in 2020, then slipped by 5.37% to $58.1 million in 2021, then fell by 5.85% to $54.7 million in 2022, then tumbled by 39.31% to $33.2 million in 2023, then retreated by 14.16% to $28.5 million in 2024.
• Business Quant data shows MD's Receivables - Other at $28.5 million in Q4 2024, $33.2 million in Q4 2023, and $54.7 million in Q4 2022.